116 related articles for article (PubMed ID: 36560517)
21. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
22. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
[TBL] [Abstract][Full Text] [Related]
23. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review.
Shenoy S
World J Crit Care Med; 2021 Jul; 10(4):132-150. PubMed ID: 34316448
[TBL] [Abstract][Full Text] [Related]
25. A phylogenetic perspective of antiviral species of the genus
Hussain A
J Herb Med; 2022 Dec; 36():100601. PubMed ID: 36188629
[TBL] [Abstract][Full Text] [Related]
26. Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
Undi RB; Larabee JL; Filiberti A; Ulahannan S; Aravindan S; Stroberg E; Barton LM; Duval EJ; Mukhopadhyay S; Henthorn JC; Akins D; Houchen CW; Huycke MM; Ali N
J Virol; 2022 Sep; 96(17):e0096722. PubMed ID: 35943255
[TBL] [Abstract][Full Text] [Related]
27. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
Choi YM; Jeong H; Park U; Cho NH; Kim BJ
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202029
[TBL] [Abstract][Full Text] [Related]
28. Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Salas Rojas M; Silva Garcia R; Bini E; Pérez de la Cruz V; León Contreras JC; Hernández Pando R; Bastida Gonzalez F; Davila-Gonzalez E; Orozco Morales M; Gamboa Domínguez A; Sotelo J; Pineda B
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477376
[TBL] [Abstract][Full Text] [Related]
29. CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells.
Lotti V; Merigo F; Lagni A; Di Clemente A; Ligozzi M; Bernardi P; Rossini G; Concia E; Plebani R; Romano M; Sbarbati A; Sorio C; Gibellini D
Cells; 2022 Apr; 11(8):. PubMed ID: 35456026
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
Ma Q; Xie Y; Wang Z; Lei B; Chen R; Liu B; Jiang H; Wang Y; Liu Q; Yang Z
J Ethnopharmacol; 2021 Oct; 279():114367. PubMed ID: 34174375
[TBL] [Abstract][Full Text] [Related]
31. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection.
Cervantes-Barragan L; Vanderheiden A; Royer CJ; Davis-Gardner ME; Ralfs P; Chirkova T; Anderson LJ; Grakoui A; Suthar MS
bioRxiv; 2021 May; ():. PubMed ID: 34013278
[TBL] [Abstract][Full Text] [Related]
32. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
[TBL] [Abstract][Full Text] [Related]
33. Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review.
Jefferson T; Spencer EA; Conly JM; Rosca EC; Maltoni S; Brassey J; Onakpoya IJ; Evans DH; Heneghan CJ; Plüddemann A
J Hosp Infect; 2023 Feb; 132():62-72. PubMed ID: 36473552
[TBL] [Abstract][Full Text] [Related]
34. Potential role of IFN-α in COVID-19 patients and its underlying treatment options.
Yang L; Wang J; Hui P; Yarovinsky TO; Badeti S; Pham K; Liu C
Appl Microbiol Biotechnol; 2021 May; 105(10):4005-4015. PubMed ID: 33950278
[TBL] [Abstract][Full Text] [Related]
35. The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.
Nilsson-Payant BE; Uhl S; Grimont A; Doane AS; Cohen P; Patel RS; Higgins CA; Acklin JA; Bram Y; Chandar V; Blanco-Melo D; Panis M; Lim JK; Elemento O; Schwartz RE; Rosenberg BR; Chandwani R; tenOever BR
J Virol; 2021 Nov; 95(23):e0125721. PubMed ID: 34523966
[TBL] [Abstract][Full Text] [Related]
36. JAX2, an ethanol extract of Hyssopus cuspidatus Boriss, can prevent bronchial asthma by inhibiting MAPK/NF-κB inflammatory signaling.
Yuan F; Liu R; Hu M; Rong X; Bai L; Xu L; Mao Y; Hasimu H; Sun Y; He J
Phytomedicine; 2019 Apr; 57():305-314. PubMed ID: 30807985
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
Meyer K; Patra T; Vijayamahantesh ; Ray R
J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250
[TBL] [Abstract][Full Text] [Related]
38. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.
Lokugamage KG; Hage A; de Vries M; Valero-Jimenez AM; Schindewolf C; Dittmann M; Rajsbaum R; Menachery VD
J Virol; 2020 Nov; 94(23):. PubMed ID: 32938761
[TBL] [Abstract][Full Text] [Related]
39. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
